A COPD Quality Improvement Program（QIP）

QIP(Quality Improvement Programme) is a COPD quality improvement program in China. The initial step of this program is to set up the Quality Standards(QS) of COPD management in clinical practice, then embed Quality Standards into routine care and uses Quality Control Indicators (QCI)to check the QS implementation. The aim of the QIP program is to standardize COPD management in clinical practice in China, including the standardization of diagnosis, assessment, pharmacological and non-pharmacological intervention, and follow-up. COPD patients can benefit from standardization clinical behaviours, to be identified early, be accessed comprehensively, and be treated correctly according to guidelines, and with an appropriate follow-up to improve adherence.

Inclusion Criteria:Diagnosed with COPDAged 40 years or olderCAT≥10With exacerbation history：at least 2 moderate or 1 severe exacerbation in the previous yearor 1 moderate exacerbation in the previous year with FEV1 <50% predicted value at baseline;Must able to sign the informed consent formExclusion Criteria:Patients on triple therapy at baseline with a LAMA, LABA, and inhaled corticosteroid (ICS) combination (Including open triple and fix-dose triple)Significant diseases or conditions other than COPD, which, in the opinion of the Investigator, may put the subject at risk because of participation in the study or may influence either the results of the study or the subject's ability to participate in the studyPatients who are currently involved in any other interventional studies